MYD88 and colitis: GSK-3β was found to strongly promote the production of proinflammatory cytokines by TLR-induced MyD88-dependent and MyD88-independent pathways, and the inhibition of GSK-3β was shown to protect the host from several inflammatory diseases such as colitis, arthritis, and sepsis-induced organ failure [43].